Stocks · NASDAQ · Healthcare · United States
IOVA Stock Analysis — Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. (IOVA) is a healthcare stock listed on NASDAQ (United States). At the close of October 30, 2026 it traded at 8.48 (-11.30% on the day), -40.4% over one month, +94.5% over three months, +334.9% over twelve months. The InvestMuse composite score is +34 on a −100 to +100 scale, a bullish read that ranks #198 of about 1,289 assets. The strongest of its nine dimensions are Regime (hidden Markov model) (+95) and Momentum (+82); the weakest is Trend (-41). Its volatility regime from the hidden Markov model is Hot.
The facts
| Last close | 8.48 (October 30, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -11.30% / -40.4% / +94.5% / +334.9% |
| 52-week range | 1.81 – 14.86 |
| Composite score | +34 / 100 · bullish view · rank #198 |
| Volatility regime (HMM) | Hot |
| Market cap | $1.9B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)+95
- Technical indicators+33
- Trend-41
- Support / resistance0
- Fundamentals0
- Sector edge0
- News sentiment0
- Momentum+82
- Chart patterns and zones-15
More healthcare reads
How this read is made
Every night InvestMuse scores about 1,289 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of October 30, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.